Virtu Financial’s Humacyte Inc Warrant HUMAW Stock Holding History

Virtu Financial’s Portfolio HUMAW Stock Details HUMAW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-11,985	Closed	-$22K	–	1651
2024 Q4	$22K	Buy	+11,985	New	+$21.2K	﹤0.01%	1285
2022 Q1	–	Sell	-10,314	Closed	-$24K	–	1721
2021 Q4	$24K	Buy	+10,314	New	+$30.2K	﹤0.01%	1495

Other funds holding HUMAW

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

SCM

Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return

WAM

Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Virtu Financial's HUMAW Position: Q1 2025 in Review

Virtu Financial sold out of Humacyte Inc Warrant (HUMAW) in Q1 2025, closing a stake of 11,985 shares — an estimated $22K sold.

Virtu Financial first reported a position in HUMAW in Q4 2021 and held it in 2 quarters. The position peaked at $24K in Q4 2021. 5 funds tracked by Wall St. Rank hold HUMAW as of Q1 2025.

Virtu Financial reported no remaining Humacyte Inc Warrant position as of Q1 2025 after selling out during the quarter.
Virtu Financial sold 11,985 Humacyte Inc Warrant shares in Q1 2025, an estimated $22K.
Virtu Financial first reported a position in Humacyte Inc Warrant in Q4 2021 and held it in 2 quarters.
Virtu Financial's Humacyte Inc Warrant position peaked at $24K in Q4 2021.
5 funds tracked by Wall St. Rank held Humacyte Inc Warrant as of Q1 2025.

Based on Virtu Financial's 13F filing for Q1 2025, filed 12 May 2025.